According to a press release from Biomedical Market Newsletter, the Food and Drug Administration is planning to:
- & revisit controversies surrounding the promotion and
While this should make exhibitors and other suppliers increase their scrutiny of their practices at shows, it also means that show organizers who aren t responsible for the FDA compliance or lack thereof of their exhibitors/sponsors may have more FDA officials on their show floors. Even if it s not the show organizer s responsibility, it still doesn t look so hot when there s a writeup about FDA violations that occurred on your conference's show floor in the Wall Street Journal.
To receive a weekly update, e-mail Sue.